The application of phosphoramidate ProTide technology to the potent anti-HCV compound 4'-azidocytidine (R1479).
Identifieur interne : 001F37 ( Ncbi/Merge ); précédent : 001F36; suivant : 001F38The application of phosphoramidate ProTide technology to the potent anti-HCV compound 4'-azidocytidine (R1479).
Auteurs : Christopher Mcguigan [Royaume-Uni] ; Mary Rose Kelleher ; Plinio Perrone ; Sinead Mulready ; Giovanna Luoni ; Felice Daverio ; Sonal Rajyaguru ; Sophie Le Pogam ; Isabel Najera ; Joseph A. Martin ; Klaus Klumpp ; David B. SmithSource :
- Bioorganic & medicinal chemistry letters [ 1464-3405 ] ; 2009.
Descripteurs français
- KwdFr :
- Acides aminés (), Antiviraux (pharmacologie), Antiviraux (synthèse chimique), Chimie pharmaceutique (), Conception de médicament, Cytidine (analogues et dérivés), Cytidine (pharmacologie), Cytidine (synthèse chimique), Hepacivirus (métabolisme), Humains, Hépatite C (traitement médicamenteux), Modèles chimiques, Promédicaments, Réplication virale, Réplicon (), Technologie pharmaceutique (), Évaluation préclinique de médicament.
- MESH :
- analogues et dérivés : Cytidine.
- métabolisme : Hepacivirus.
- pharmacologie : Antiviraux, Cytidine.
- synthèse chimique : Antiviraux, Cytidine.
- traitement médicamenteux : Hépatite C.
- Acides aminés, Chimie pharmaceutique, Conception de médicament, Humains, Modèles chimiques, Promédicaments, Réplication virale, Réplicon, Technologie pharmaceutique, Évaluation préclinique de médicament.
English descriptors
- KwdEn :
- Amino Acids (chemistry), Antiviral Agents (chemical synthesis), Antiviral Agents (pharmacology), Chemistry, Pharmaceutical (methods), Cytidine (analogs & derivatives), Cytidine (chemical synthesis), Cytidine (pharmacology), Drug Design, Drug Evaluation, Preclinical, Hepacivirus (metabolism), Hepatitis C (drug therapy), Humans, Models, Chemical, Prodrugs, Replicon (drug effects), Technology, Pharmaceutical (methods), Virus Replication.
- MESH :
- chemical , analogs & derivatives : Cytidine.
- chemical , chemical synthesis : Antiviral Agents, Cytidine.
- chemical , chemistry : Amino Acids.
- chemical , pharmacology : Antiviral Agents, Cytidine.
- drug effects : Replicon.
- drug therapy : Hepatitis C.
- metabolism : Hepacivirus.
- methods : Chemistry, Pharmaceutical, Technology, Pharmaceutical.
- Drug Design, Drug Evaluation, Preclinical, Humans, Models, Chemical, Prodrugs, Virus Replication.
Abstract
We report the design, synthesis and evaluation of a family of ca 50 phosphoramidate ProTides of the potent anti-HCV compound 4'-azidocytidine (R1479), with variation on the ester, amino acid and aryl moiety of the ProTide. Sub-muM inhibitors of HCV emerge. The compounds are all non-cytotoxic in the replicon assay. We herein report detailed SARs for each of the regions of the ProTide.
DOI: 10.1016/j.bmcl.2009.05.099
PubMed: 19505826
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001887
- to stream PubMed, to step Curation: 001887
- to stream PubMed, to step Checkpoint: 001762
Links to Exploration step
pubmed:19505826Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The application of phosphoramidate ProTide technology to the potent anti-HCV compound 4'-azidocytidine (R1479).</title>
<author><name sortKey="Mcguigan, Christopher" sort="Mcguigan, Christopher" uniqKey="Mcguigan C" first="Christopher" last="Mcguigan">Christopher Mcguigan</name>
<affiliation wicri:level="1"><nlm:affiliation>Welsh School of Pharmacy, Cardiff University, Redwood Building, King Edward VII Avenue, Cardiff CF10 3NB, UK. mcguigan@cardiff.ac.uk</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Welsh School of Pharmacy, Cardiff University, Redwood Building, King Edward VII Avenue, Cardiff CF10 3NB</wicri:regionArea>
<wicri:noRegion>Cardiff CF10 3NB</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kelleher, Mary Rose" sort="Kelleher, Mary Rose" uniqKey="Kelleher M" first="Mary Rose" last="Kelleher">Mary Rose Kelleher</name>
</author>
<author><name sortKey="Perrone, Plinio" sort="Perrone, Plinio" uniqKey="Perrone P" first="Plinio" last="Perrone">Plinio Perrone</name>
</author>
<author><name sortKey="Mulready, Sinead" sort="Mulready, Sinead" uniqKey="Mulready S" first="Sinead" last="Mulready">Sinead Mulready</name>
</author>
<author><name sortKey="Luoni, Giovanna" sort="Luoni, Giovanna" uniqKey="Luoni G" first="Giovanna" last="Luoni">Giovanna Luoni</name>
</author>
<author><name sortKey="Daverio, Felice" sort="Daverio, Felice" uniqKey="Daverio F" first="Felice" last="Daverio">Felice Daverio</name>
</author>
<author><name sortKey="Rajyaguru, Sonal" sort="Rajyaguru, Sonal" uniqKey="Rajyaguru S" first="Sonal" last="Rajyaguru">Sonal Rajyaguru</name>
</author>
<author><name sortKey="Le Pogam, Sophie" sort="Le Pogam, Sophie" uniqKey="Le Pogam S" first="Sophie" last="Le Pogam">Sophie Le Pogam</name>
</author>
<author><name sortKey="Najera, Isabel" sort="Najera, Isabel" uniqKey="Najera I" first="Isabel" last="Najera">Isabel Najera</name>
</author>
<author><name sortKey="Martin, Joseph A" sort="Martin, Joseph A" uniqKey="Martin J" first="Joseph A" last="Martin">Joseph A. Martin</name>
</author>
<author><name sortKey="Klumpp, Klaus" sort="Klumpp, Klaus" uniqKey="Klumpp K" first="Klaus" last="Klumpp">Klaus Klumpp</name>
</author>
<author><name sortKey="Smith, David B" sort="Smith, David B" uniqKey="Smith D" first="David B" last="Smith">David B. Smith</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2009">2009</date>
<idno type="RBID">pubmed:19505826</idno>
<idno type="pmid">19505826</idno>
<idno type="doi">10.1016/j.bmcl.2009.05.099</idno>
<idno type="wicri:Area/PubMed/Corpus">001887</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001887</idno>
<idno type="wicri:Area/PubMed/Curation">001887</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001887</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001762</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001762</idno>
<idno type="wicri:Area/Ncbi/Merge">001F37</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">The application of phosphoramidate ProTide technology to the potent anti-HCV compound 4'-azidocytidine (R1479).</title>
<author><name sortKey="Mcguigan, Christopher" sort="Mcguigan, Christopher" uniqKey="Mcguigan C" first="Christopher" last="Mcguigan">Christopher Mcguigan</name>
<affiliation wicri:level="1"><nlm:affiliation>Welsh School of Pharmacy, Cardiff University, Redwood Building, King Edward VII Avenue, Cardiff CF10 3NB, UK. mcguigan@cardiff.ac.uk</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Welsh School of Pharmacy, Cardiff University, Redwood Building, King Edward VII Avenue, Cardiff CF10 3NB</wicri:regionArea>
<wicri:noRegion>Cardiff CF10 3NB</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kelleher, Mary Rose" sort="Kelleher, Mary Rose" uniqKey="Kelleher M" first="Mary Rose" last="Kelleher">Mary Rose Kelleher</name>
</author>
<author><name sortKey="Perrone, Plinio" sort="Perrone, Plinio" uniqKey="Perrone P" first="Plinio" last="Perrone">Plinio Perrone</name>
</author>
<author><name sortKey="Mulready, Sinead" sort="Mulready, Sinead" uniqKey="Mulready S" first="Sinead" last="Mulready">Sinead Mulready</name>
</author>
<author><name sortKey="Luoni, Giovanna" sort="Luoni, Giovanna" uniqKey="Luoni G" first="Giovanna" last="Luoni">Giovanna Luoni</name>
</author>
<author><name sortKey="Daverio, Felice" sort="Daverio, Felice" uniqKey="Daverio F" first="Felice" last="Daverio">Felice Daverio</name>
</author>
<author><name sortKey="Rajyaguru, Sonal" sort="Rajyaguru, Sonal" uniqKey="Rajyaguru S" first="Sonal" last="Rajyaguru">Sonal Rajyaguru</name>
</author>
<author><name sortKey="Le Pogam, Sophie" sort="Le Pogam, Sophie" uniqKey="Le Pogam S" first="Sophie" last="Le Pogam">Sophie Le Pogam</name>
</author>
<author><name sortKey="Najera, Isabel" sort="Najera, Isabel" uniqKey="Najera I" first="Isabel" last="Najera">Isabel Najera</name>
</author>
<author><name sortKey="Martin, Joseph A" sort="Martin, Joseph A" uniqKey="Martin J" first="Joseph A" last="Martin">Joseph A. Martin</name>
</author>
<author><name sortKey="Klumpp, Klaus" sort="Klumpp, Klaus" uniqKey="Klumpp K" first="Klaus" last="Klumpp">Klaus Klumpp</name>
</author>
<author><name sortKey="Smith, David B" sort="Smith, David B" uniqKey="Smith D" first="David B" last="Smith">David B. Smith</name>
</author>
</analytic>
<series><title level="j">Bioorganic & medicinal chemistry letters</title>
<idno type="eISSN">1464-3405</idno>
<imprint><date when="2009" type="published">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Amino Acids (chemistry)</term>
<term>Antiviral Agents (chemical synthesis)</term>
<term>Antiviral Agents (pharmacology)</term>
<term>Chemistry, Pharmaceutical (methods)</term>
<term>Cytidine (analogs & derivatives)</term>
<term>Cytidine (chemical synthesis)</term>
<term>Cytidine (pharmacology)</term>
<term>Drug Design</term>
<term>Drug Evaluation, Preclinical</term>
<term>Hepacivirus (metabolism)</term>
<term>Hepatitis C (drug therapy)</term>
<term>Humans</term>
<term>Models, Chemical</term>
<term>Prodrugs</term>
<term>Replicon (drug effects)</term>
<term>Technology, Pharmaceutical (methods)</term>
<term>Virus Replication</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Acides aminés ()</term>
<term>Antiviraux (pharmacologie)</term>
<term>Antiviraux (synthèse chimique)</term>
<term>Chimie pharmaceutique ()</term>
<term>Conception de médicament</term>
<term>Cytidine (analogues et dérivés)</term>
<term>Cytidine (pharmacologie)</term>
<term>Cytidine (synthèse chimique)</term>
<term>Hepacivirus (métabolisme)</term>
<term>Humains</term>
<term>Hépatite C (traitement médicamenteux)</term>
<term>Modèles chimiques</term>
<term>Promédicaments</term>
<term>Réplication virale</term>
<term>Réplicon ()</term>
<term>Technologie pharmaceutique ()</term>
<term>Évaluation préclinique de médicament</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Cytidine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemical synthesis" xml:lang="en"><term>Antiviral Agents</term>
<term>Cytidine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Amino Acids</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Antiviral Agents</term>
<term>Cytidine</term>
</keywords>
<keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr"><term>Cytidine</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Replicon</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Hepatitis C</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Hepacivirus</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Chemistry, Pharmaceutical</term>
<term>Technology, Pharmaceutical</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Hepacivirus</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Antiviraux</term>
<term>Cytidine</term>
</keywords>
<keywords scheme="MESH" qualifier="synthèse chimique" xml:lang="fr"><term>Antiviraux</term>
<term>Cytidine</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Hépatite C</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Drug Design</term>
<term>Drug Evaluation, Preclinical</term>
<term>Humans</term>
<term>Models, Chemical</term>
<term>Prodrugs</term>
<term>Virus Replication</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Acides aminés</term>
<term>Chimie pharmaceutique</term>
<term>Conception de médicament</term>
<term>Humains</term>
<term>Modèles chimiques</term>
<term>Promédicaments</term>
<term>Réplication virale</term>
<term>Réplicon</term>
<term>Technologie pharmaceutique</term>
<term>Évaluation préclinique de médicament</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We report the design, synthesis and evaluation of a family of ca 50 phosphoramidate ProTides of the potent anti-HCV compound 4'-azidocytidine (R1479), with variation on the ester, amino acid and aryl moiety of the ProTide. Sub-muM inhibitors of HCV emerge. The compounds are all non-cytotoxic in the replicon assay. We herein report detailed SARs for each of the regions of the ProTide.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19505826</PMID>
<DateCompleted><Year>2009</Year>
<Month>12</Month>
<Day>07</Day>
</DateCompleted>
<DateRevised><Year>2019</Year>
<Month>01</Month>
<Day>07</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1464-3405</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>19</Volume>
<Issue>15</Issue>
<PubDate><Year>2009</Year>
<Month>Aug</Month>
<Day>01</Day>
</PubDate>
</JournalIssue>
<Title>Bioorganic & medicinal chemistry letters</Title>
<ISOAbbreviation>Bioorg. Med. Chem. Lett.</ISOAbbreviation>
</Journal>
<ArticleTitle>The application of phosphoramidate ProTide technology to the potent anti-HCV compound 4'-azidocytidine (R1479).</ArticleTitle>
<Pagination><MedlinePgn>4250-4</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bmcl.2009.05.099</ELocationID>
<Abstract><AbstractText>We report the design, synthesis and evaluation of a family of ca 50 phosphoramidate ProTides of the potent anti-HCV compound 4'-azidocytidine (R1479), with variation on the ester, amino acid and aryl moiety of the ProTide. Sub-muM inhibitors of HCV emerge. The compounds are all non-cytotoxic in the replicon assay. We herein report detailed SARs for each of the regions of the ProTide.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McGuigan</LastName>
<ForeName>Christopher</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Welsh School of Pharmacy, Cardiff University, Redwood Building, King Edward VII Avenue, Cardiff CF10 3NB, UK. mcguigan@cardiff.ac.uk</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kelleher</LastName>
<ForeName>Mary Rose</ForeName>
<Initials>MR</Initials>
</Author>
<Author ValidYN="Y"><LastName>Perrone</LastName>
<ForeName>Plinio</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y"><LastName>Mulready</LastName>
<ForeName>Sinead</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y"><LastName>Luoni</LastName>
<ForeName>Giovanna</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y"><LastName>Daverio</LastName>
<ForeName>Felice</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y"><LastName>Rajyaguru</LastName>
<ForeName>Sonal</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y"><LastName>Le Pogam</LastName>
<ForeName>Sophie</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y"><LastName>Najera</LastName>
<ForeName>Isabel</ForeName>
<Initials>I</Initials>
</Author>
<Author ValidYN="Y"><LastName>Martin</LastName>
<ForeName>Joseph A</ForeName>
<Initials>JA</Initials>
</Author>
<Author ValidYN="Y"><LastName>Klumpp</LastName>
<ForeName>Klaus</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y"><LastName>Smith</LastName>
<ForeName>David B</ForeName>
<Initials>DB</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2009</Year>
<Month>05</Month>
<Day>29</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Bioorg Med Chem Lett</MedlineTA>
<NlmUniqueID>9107377</NlmUniqueID>
<ISSNLinking>0960-894X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000596">Amino Acids</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011355">Prodrugs</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>5CSZ8459RP</RegistryNumber>
<NameOfSubstance UI="D003562">Cytidine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>M71RA9DMGJ</RegistryNumber>
<NameOfSubstance UI="C508950">4'-azidocytidine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000596" MajorTopicYN="N">Amino Acids</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000138" MajorTopicYN="Y">chemical synthesis</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002626" MajorTopicYN="N">Chemistry, Pharmaceutical</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003562" MajorTopicYN="N">Cytidine</DescriptorName>
<QualifierName UI="Q000031" MajorTopicYN="Y">analogs & derivatives</QualifierName>
<QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015195" MajorTopicYN="N">Drug Design</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004353" MajorTopicYN="N">Drug Evaluation, Preclinical</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016174" MajorTopicYN="N">Hepacivirus</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006526" MajorTopicYN="N">Hepatitis C</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008956" MajorTopicYN="N">Models, Chemical</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011355" MajorTopicYN="N">Prodrugs</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012093" MajorTopicYN="N">Replicon</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013678" MajorTopicYN="N">Technology, Pharmaceutical</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2009</Year>
<Month>04</Month>
<Day>15</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2009</Year>
<Month>05</Month>
<Day>21</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2009</Year>
<Month>05</Month>
<Day>22</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2009</Year>
<Month>6</Month>
<Day>10</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2009</Year>
<Month>6</Month>
<Day>10</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2009</Year>
<Month>12</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">19505826</ArticleId>
<ArticleId IdType="pii">S0960-894X(09)00790-2</ArticleId>
<ArticleId IdType="doi">10.1016/j.bmcl.2009.05.099</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Royaume-Uni</li>
</country>
</list>
<tree><noCountry><name sortKey="Daverio, Felice" sort="Daverio, Felice" uniqKey="Daverio F" first="Felice" last="Daverio">Felice Daverio</name>
<name sortKey="Kelleher, Mary Rose" sort="Kelleher, Mary Rose" uniqKey="Kelleher M" first="Mary Rose" last="Kelleher">Mary Rose Kelleher</name>
<name sortKey="Klumpp, Klaus" sort="Klumpp, Klaus" uniqKey="Klumpp K" first="Klaus" last="Klumpp">Klaus Klumpp</name>
<name sortKey="Le Pogam, Sophie" sort="Le Pogam, Sophie" uniqKey="Le Pogam S" first="Sophie" last="Le Pogam">Sophie Le Pogam</name>
<name sortKey="Luoni, Giovanna" sort="Luoni, Giovanna" uniqKey="Luoni G" first="Giovanna" last="Luoni">Giovanna Luoni</name>
<name sortKey="Martin, Joseph A" sort="Martin, Joseph A" uniqKey="Martin J" first="Joseph A" last="Martin">Joseph A. Martin</name>
<name sortKey="Mulready, Sinead" sort="Mulready, Sinead" uniqKey="Mulready S" first="Sinead" last="Mulready">Sinead Mulready</name>
<name sortKey="Najera, Isabel" sort="Najera, Isabel" uniqKey="Najera I" first="Isabel" last="Najera">Isabel Najera</name>
<name sortKey="Perrone, Plinio" sort="Perrone, Plinio" uniqKey="Perrone P" first="Plinio" last="Perrone">Plinio Perrone</name>
<name sortKey="Rajyaguru, Sonal" sort="Rajyaguru, Sonal" uniqKey="Rajyaguru S" first="Sonal" last="Rajyaguru">Sonal Rajyaguru</name>
<name sortKey="Smith, David B" sort="Smith, David B" uniqKey="Smith D" first="David B" last="Smith">David B. Smith</name>
</noCountry>
<country name="Royaume-Uni"><noRegion><name sortKey="Mcguigan, Christopher" sort="Mcguigan, Christopher" uniqKey="Mcguigan C" first="Christopher" last="Mcguigan">Christopher Mcguigan</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001F37 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 001F37 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= Ncbi |étape= Merge |type= RBID |clé= pubmed:19505826 |texte= The application of phosphoramidate ProTide technology to the potent anti-HCV compound 4'-azidocytidine (R1479). }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:19505826" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
This area was generated with Dilib version V0.6.33. |